Effect of Vitex negundo L. seeds in letrozole induced polycystic ovarian syndrome

Maharjan, 2010, Effect of Aloe barbadensis Mill. formulation on Letrozole induced polycystic ovarian syndrome rat model, J Ayurveda Integr Med Poretsky, 1992, Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats, Metabolism, 41, 903, 10.1016/0026-0495(92)90175-A Badawy, 2011, Treatment options for polycystic ovary syndrome, Int J Womens Health, 3, 25, 10.2147/IJWH.S11304 Choi, 2005, Psychological side-effects of clomiphene citrate and human menopausal gonadotrophin, J Psychosom Obstet Gynecol, 26, 93, 10.1080/01443610400022983 Dunaif, 2008, Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome—a reappraisal, Nat Rev Endocrinol, 4, 272, 10.1038/ncpendmet0787 Arentz, 2014, Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings, BMC Compl Alternative Med, 14, 1 Ried, 2015, Chinese herbal medicine for female infertility: an updated meta-analysis, Compl Ther Med, 23, 116, 10.1016/j.ctim.2014.12.004 Hosseinkhani, 2018, Traditional Persian Medicine and management of metabolic dysfunction in polycystic ovary syndrome, J Tradit Complementary Med, 8, 17, 10.1016/j.jtcme.2017.04.006 Borzoei, 2018, Effects of cinnamon supplementation on antioxidant status and serum lipids in women with polycystic ovary syndrome, J Tradit Complementary Med., 8, 128, 10.1016/j.jtcme.2017.04.008 Vishwanathan, 2010, A review on Vitex negundo L–a medicinally important plant, Eur J Biol Sci, 3, 30 Tandon, 2005, Medicinal uses and biological activities of Vitex negundo, Nat Prod Radiance, 4, 162 Dharmasiri, 2003, Anti-inflammatory and analgesic activities of mature fresh leaves of Vitex negundo, J Ethnopharmacol, 87, 199, 10.1016/S0378-8741(03)00159-4 Kulkarni, 2008, Antioxidant and antiinflammatory activity of Vitex negundo, Indian J Pharmaceut Sci, 70, 838, 10.4103/0250-474X.49140 Sathiamoorthy, 2007, New antifungal flavonoid glycoside from Vitex negundo, Bioorg Med Chem Lett, 17, 239, 10.1016/j.bmcl.2006.09.051 Karunamoorthi, 2008, Evaluation of leaf extracts of Vitex negundo L. (Family: verbenaceae) against larvae of Culex tritaeniorhynchus and repellent activity on adult vector mosquitoes, Parasitol Res, 103, 545, 10.1007/s00436-008-1005-5 Sundaram, 2012, Antihyperglycemic effect of iridoid glucoside, isolated from the leaves of Vitex negundo in streptozotocin-induced diabetic rats with special reference to glycoprotein components, Phytomedicine, 19, 211, 10.1016/j.phymed.2011.10.006 Bhargava, 1989, Antiandrogenic effects of a flavonoid-rich fraction of Vitex negundo seeds: a histological and biochemical study in dogs, J Ethnopharmacol, 27, 327, 10.1016/0378-8741(89)90007-X Hu, 2007, Estrogen-like activities in Vitex species from China determined by a cell based proliferation assay, Pharmazie, 62, 872 Chang, 2002, Estimation of total flavonoid content in propolis by two complementary colorimetric methods, J Food Drug Anal, 10 Ayurvedic Pharmacopiea of India. In: welfare MohaF, ed. Vol. vol. 5. India:183. Medhi, 2010 Petchi, 2014, Antidiabetic activity of polyherbal formulation in streptozotocin - nicotinamide induced diabetic wistar rats, J Tradit Complementary Med, 4, 108, 10.4103/2225-4110.126174 Sarvankumar, 2011, Nephroprotective activity of Vitex negundo Linn bark against chemical induced toxicity in experimenal Rats, Int J Adv Pharmaceut Sci, 2, 462 Kafali, 2004, Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease, Arch Med Res, 35, 103, 10.1016/j.arcmed.2003.10.005 Robertson, 1991, Circulating half-lives of follicle-stimulating hormone and luteinizing hormone in pituitary extracts and isoform fractions of ovariectomized and intact ewes, Endocrine, 129, 1805, 10.1210/endo-129-4-1805 Shivanandappa, 1997, A colorimetric assay method for 3β-hydroxy-Δ 5-steroid dehydrogenase, Anal Chem, 254, 57 Du Vigneaud, 1925, Carbohydrate utilization I. Rate of disappearance of d-glucose from the blood, J Biol Chem, 66, 281, 10.1016/S0021-9258(18)84814-1 Wang, 2012, Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats, J Ovarian Res, 5, 1 Meena, 2011, A review of the important chemical constituents and medicinal uses of Vitex genus, Asian J Tradit Med, 6, 54 Roy, 2009, Changing concepts in polycystic ovarian syndrome, Apollo Med, 6, 222, 10.1016/S0976-0016(11)60531-0 Franks, 2002, Adult polycystic ovary syndrome begins in childhood, Best Pract Res Clin Endocrinol Metabol, 16, 263, 10.1053/beem.2002.0203 Mahajan, 1988, Polycystic ovarian disease: animal models, Endocrinol Metab Clin N Am, 17, 705, 10.1016/S0889-8529(18)30406-7 Mahesh, 1987, Animal models for study of polycystic ovaries and ovarian atresia, Adv Exp Med Biol, 219, 237, 10.1007/978-1-4684-5395-9_12 Clark, 1995, Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women, Hum Reprod, 10, 2705, 10.1093/oxfordjournals.humrep.a135772 Holte, 1994, Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance, J Clin Endocrinol Metab, 78, 1052 Gambineri, 2002, Obesity and the polycystic ovary syndrome, Int J Obes Relat Metab Disord, 26, 10.1038/sj.ijo.0801994 Barber, 2006, Obesity and polycystic ovary syndrome, Clin Endocrinol, 65, 137, 10.1111/j.1365-2265.2006.02587.x Sundblad, 1994, High levels of free testosterone in women with bulimia nervosa, Acta Psychiatr Scand, 90, 397, 10.1111/j.1600-0447.1994.tb01613.x Naessen, 2007, Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women, Psychoneuroendocrinology, 32, 548, 10.1016/j.psyneuen.2007.03.008 Xiang, 2012, Relationship between serum lipoprotein ratios and insulin resistance in polycystic ovary syndrome, Internet J Endocrinol, 2012 Legro, 2001, Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome, Am J Med, 111, 607, 10.1016/S0002-9343(01)00948-2 Ehrmann, 2005, Polycystic ovary syndrome, N Engl J Med, 352, 1223, 10.1056/NEJMra041536 Legro, 2005, Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study, J Clin Endocrinol Metab, 90, 3236, 10.1210/jc.2004-1843 Gagnon, 2007, Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome, Can Med Assoc J, 176, 933, 10.1503/cmaj.060607 Gougeon, 1996, Regulation of ovarian follicular development in primates: facts and hypotheses, Endocr Rev, 17, 121, 10.1210/edrv-17-2-121 Hillier, 1981, Control of preovulatory follicular estrogen biosynthesis in the human ovary, J Clin Endocrinol Metab, 52, 847, 10.1210/jcem-52-5-847 Eden, 1990, Follicular fluid concentrations of insulin-like growth factor 1, epidermal growth factor, transforming growth factor-alpha and sex-steroids in volume matched normal and polycystic human follicles, Clin Endocrinol, 32, 395, 10.1111/j.1365-2265.1990.tb00879.x Arroyo, 1997, Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity 1, J Clin Endocrinol Metab, 82, 3728 Taylor, 1997, Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome 1, J Clin Endocrinol Metab, 82, 2248 Cheung, 1995, Endocrinology: pituitary responsiveness to gonadotrophin-releasing hormone agonist stimulation: a dose—response comparison of luteinizing hormone/follicle-stimulating hormone secretion in women with polycystic ovary syndrome and normal women, Hum Reprod, 10, 1054, 10.1093/oxfordjournals.humrep.a136093